Litigation Details for Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc. (D. Del. 2018)
✉ Email this page to a colleague
Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc. (D. Del. 2018)
Docket | ⤷ Try a Trial | Date Filed | 2018-12-11 |
Court | District Court, D. Delaware | Date Terminated | 2021-05-17 |
Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
Jury Demand | None | Referred To | |
Parties | BIONPHARMA INC. | ||
Patents | 10,039,745; 10,154,987; 10,183,004; 10,232,003; 10,279,012; 10,279,014; 6,168,016; 6,211,244; 6,316,460; 8,183,002; 8,222,015; 8,568,747; 9,194,011; 9,242,011; 9,297,019; 9,375,405; 9,669,008; 9,808,442 | ||
Attorneys | Kristina A. Hanson | ||
Firms | Morris, Nichols, Arsht & Tunnell | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc.
Biologic Drugs cited in Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Silvergate Pharmaceuticals, Inc. v. Bionpharma Inc. (D. Del. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2020-12-13 | and Counterclaims with Respect to U.S. Patent Nos. 9,669,008 and 9,808,442 filed by Silvergate Pharmaceuticals… 2018 17 May 2021 1:18-cv-01962 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | ||
2020-07-22 | 136 | Notice of Service | Byrn on Infringement of U.S. Patent Nos. 9,669,008; 9,808,442; 10,039,745; and 10,154,987; and (2) Opening…John D. Mahan, Jr., M.D. on Infringement of U.S. Patent 9,808,442 and 10,154,987 filed by Silvergate Pharmaceuticals… 2018 17 May 2021 1:18-cv-01962 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2020-10-19 | 145 | Notice of Service | Stephen Byrn on the Infringement of U.S. Patents 10,039,745 and 10,154,987 filed by Silvergate Pharmaceuticals… 2018 17 May 2021 1:18-cv-01962 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |